The CNIO fired the senior executive who reported alleged favoritism towards Barbacid with two patents
The CNIO terminated the employment of Roke Oruezabal after he reported potential favoritism in the allocation of patents to Mariano Barbacid.
The CNIO ruled out the patent as 'too weak' with which Barbacid has already raised 3.5 million against pancreatic cancer
The CNIO dismissed a patent related to pancreatic cancer treatment proposed by scientist Mariano Barbacid, citing insufficient novelty and inventive activity.
The long distance from 'cure' for cancer in mice to humans
Scientist Laura Soucek emphasizes the need for honest communication regarding experimental cancer treatments for humans, cautioning against creating false hopes based on mouse studies.
Medication in Mice is Not the Same as Medication in Humans: About How the Report of Scientists Finding a Cure for Pancreatic Cancer Inflated
Recent claims of a breakthrough cure for pancreatic cancer by Spanish scientists have led to overwhelming inquiries from patients, but the implications of such a treatment's effectiveness in humans remain uncertain.
Pancreatic cancer: a specialist explained in detail why it was eliminated in mice in Spain and how it works
A team of Spanish scientists has successfully eradicated the most common type of pancreatic cancer in mice, reflecting a significant breakthrough in oncology.
What we have achieved in pancreatic cancer has never been done before. Should I say it's nonsense?
Spanish scientist Mariano Barbacid has developed a triple therapy that successfully eliminates pancreatic tumors in mice, making significant strides in cancer research.
The True Story Behind 'The First Effective Therapy Against Pancreatic Cancer' by Mariano Barbacid
Mariano Barbacid's company Vega Oncotargets has toned down its slogan after generating false expectations from a promising experiment involving 45 'cured' mice, prompting over a hundred pancreatic cancer patients to seek assistance from the CNIO.
Aurelio Rojas, cardiologist, furious about public money to be allocated to Broncano
Cardiologist Aurelio Rojas expresses anger over public funds being allocated to pay entertainer Broncano instead of supporting researcher Mariano Barbacid.
Concern over the expectations created by Barbacid about pancreatic cancer: 'The announcement has gotten out of hand'
The National Center for Cancer Research (CNIO) has seen an unprecedented number of inquiries following Mariano Barbacid's announcement of successfully eliminating a type of pancreatic cancer in mice using a combination of three drugs.
Cris Against Cancer launches a campaign to fund research by Mariano Barbacid and nearly 40,000 people support the initiative
The Cris Against Cancer Foundation has launched a fundraising campaign to finance research led by Dr. Mariano Barbacid, aiming to support pancreatic cancer projects after the team's excellent results were announced.
A "historic milestone" against pancreatic cancer: Mariano Barbacid details when patients could benefit
Oncologist Mariano Barbacid has achieved a significant breakthrough by completely eliminating pancreatic cancer in mice, offering hope for future patient treatments.
Mariano Barbacid against pancreatic cancer: the researcher and his team ask for help to start clinical trials
Mariano Barbacid and his team have developed a groundbreaking therapy that completely cured the most common form of pancreatic cancer in mice and are seeking assistance to begin clinical trials.